These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27840188)

  • 1. Lower hemoglobin levels in patients with parkinson's disease are associated with disease severity and iron metabolism.
    Deng Q; Zhou X; Chen J; Pan M; Gao H; Zhou J; Wang D; Chen Q; Zhang X; Wang Q; Xu Y
    Brain Res; 2017 Jan; 1655():145-151. PubMed ID: 27840188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's Disease is Accompanied by Intertwined Alterations in Iron Metabolism and Activated Immune-inflammatory and Oxidative Stress Pathways.
    de Farias CC; Maes M; Bonifacio KL; Matsumoto AK; Bortolasci CC; Nogueira AS; Brinholi FF; Morimoto HK; de Melo LB; Moreira EG; Barbosa DS
    CNS Neurol Disord Drug Targets; 2017; 16(4):484-491. PubMed ID: 28240188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The serum ferrokinetics in Parkinson's disease.
    Chen WH; Shih PY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1992 Nov; 8(11):581-4. PubMed ID: 1296037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low plasma uric acid level in Parkinson's disease.
    Annanmaki T; Muuronen A; Murros K
    Mov Disord; 2007 Jun; 22(8):1133-7. PubMed ID: 17443703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation of serum uric acid levels with L-Dopa treatment and progression in patients with Parkinson's disease.
    Vieru E; Köksal A; Mutluay B; Dirican AC; Altunkaynak Y; Baybas S
    Neurol Sci; 2016 May; 37(5):743-7. PubMed ID: 26753800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.
    Medeiros MS; Schumacher-Schuh A; Cardoso AM; Bochi GV; Baldissarelli J; Kegler A; Santana D; Chaves CM; Schetinger MR; Moresco RN; Rieder CR; Fighera MR
    PLoS One; 2016; 11(1):e0146129. PubMed ID: 26751079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haptoglobin phenotype modifies serum iron levels and the effect of smoking on Parkinson disease risk.
    Costa-Mallen P; Zabetian CP; Agarwal P; Hu SC; Yearout D; Samii A; Leverenz JB; Roberts JW; Checkoway H
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1087-92. PubMed ID: 26228081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral iron metabolism in patients with Parkinson's disease.
    Cabrera-Valdivia F; Jiménez-Jiménez FJ; Molina JA; Férnandez-Calle P; Vázquez A; Cañizares-Liébana F; Larumbe-Lobalde S; Ayuso-Peralta L; Rabasa M; Codoceo R
    J Neurol Sci; 1994 Aug; 125(1):82-6. PubMed ID: 7964893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological profiles of urate, paraoxonase-1, ferritin and lipid in Parkinson's disease: changes linked to disease progression.
    Ikeda K; Nakamura Y; Kiyozuka T; Aoyagi J; Hirayama T; Nagata R; Ito H; Iwamoto K; Murata K; Yoshii Y; Kawabe K; Iwasaki Y
    Neurodegener Dis; 2011; 8(4):252-8. PubMed ID: 21282940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital.
    Ojo OO; Oladipo OO; Ojini FI; Sanya EO; Danesi MA; Okubadejo NU
    West Afr J Med; 2011; 30(5):319-24. PubMed ID: 22752818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron deficient children and significance of serum ferritin.
    Khan AS; Shah SA
    J Pak Med Assoc; 2005 Oct; 55(10):420-3. PubMed ID: 16304848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low levels of serum ferritin and moderate transferrin saturation lead to adequate hemoglobin levels in hemodialysis patients, retrospective observational study.
    Ogawa C; Tsuchiya K; Tomosugi N; Kanda F; Maeda K; Maeda T
    PLoS One; 2017; 12(6):e0179608. PubMed ID: 28662118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking and haptoglobin phenotype modulate serum ferritin and haptoglobin levels in Parkinson disease.
    Costa-Mallen P; Zabetian CP; Hu SC; Agarwal P; Yearout D; Checkoway H
    J Neural Transm (Vienna); 2016 Nov; 123(11):1319-1330. PubMed ID: 27349967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of systemic inflammation and brain iron deposition in Parkinson's disease patients.
    Xu J; He X; Xu Y; Chen X; Li M; Zhang L; Fu X; Pan M; Wang Q; Hu X
    Ann Clin Transl Neurol; 2022 Mar; 9(3):276-285. PubMed ID: 35078271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma transferrin level correlates with the tremor-dominant phenotype of Parkinson's disease.
    Si QQ; Yuan YS; Zhi Y; Tong Q; Zhang L; Zhang K
    Neurosci Lett; 2018 Sep; 684():42-46. PubMed ID: 29981876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between abnormal iron metabolism and non-motor symptoms in Parkinson's disease.
    Xu W; Zhi Y; Yuan Y; Zhang B; Shen Y; Zhang H; Zhang K; Xu Y
    J Neural Transm (Vienna); 2018 Jul; 125(7):1027-1032. PubMed ID: 29748849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain iron concentrations in regions of interest and relation with serum iron levels in Parkinson disease.
    Costa-Mallen P; Gatenby C; Friend S; Maravilla KR; Hu SC; Cain KC; Agarwal P; Anzai Y
    J Neurol Sci; 2017 Jul; 378():38-44. PubMed ID: 28566175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of repeated blood donations on the iron status of Iranian blood donors attending the Iranian blood transfusion organization.
    Djalali M; Neyestani TR; Bateni J; Siassi F
    Int J Vitam Nutr Res; 2006 May; 76(3):132-7. PubMed ID: 17048192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron deficiency and hematological changes in adult patients after Fontan operation.
    Tomkiewicz-Pajak L; Plazak W; Kolcz J; Pajak J; Kopec G; Dluzniewska N; Olszowska M; Moryl-Bujakowska A; Podolec P
    J Cardiol; 2014 Nov; 64(5):384-9. PubMed ID: 24698006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Content of Reticulocyte Hemoglobin and Serum Concentration of the Soluble Transferrin Receptor for Diagnostics of Anemia in Chronically Hemodialyzed Patients.
    Kurzawa T; Owczarek A; Strzelczyk JK; Gołąbek K; Wiczkowski A
    Adv Clin Exp Med; 2016; 25(3):425-31. PubMed ID: 27629729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.